|
EP3093014A1
|
|
Cabazitaxel and its use for treating cancer
|
|
AU2015200149A1
|
|
Novel antitumoral use of cabazitaxel
|
|
TW201540296A
|
|
Use of cabazitaxel in patients with advanced gastric adenocarcinoma who have failed prior chemotherapy regimens
|
|
TW201542201A
|
|
Use of CABAZITAXEL in patients with metastatic NSCLC progressing after docetaxel-based treatment
|
|
TN2014000342A1
|
|
New pediatric uses of cabazitaxel
|
|
TW201438714A
|
|
Cabazitaxel and its use for treating metastatic prostate cancers
|
|
AU2013205442A1
|
|
Crystalline forms of dimethoxy docetaxel and methods for preparing same
|
|
TW201336493A
|
|
New pediatric uses of cabazitaxel
|
|
AU2013217964A1
|
|
New pediatric uses of cabazitaxel
|
|
WO2013088335A1
|
|
Crystalline form of cabazitaxel and process for preparing the same
|
|
AU2012227181A1
|
|
Direct Dissolution Of Docetaxel In A Solvent In Polysorbate 80
|
|
WO2013014107A1
|
|
Semuloparin for improving the survival of patients with cancer
|
|
TW201309286A
|
|
Pharmaceutical composition comprising ketoprofen
|
|
BR112013029790A2
|
|
Pharmaceutical composition comprising ketoprofen
|
|
TW201306848A
|
|
Semuloparin for the prevention of venous thromboembolism in cancer patients receiving chemotherapy
|
|
EP2706990A1
|
|
Semuloparin for the prevention of venous thromboembolism in cancer patients receiving chemotherapy
|
|
EP2656851A1
|
|
Semuloparin for improving the survival of patients with cancer
|
|
AU2012201835A1
|
|
Cholesterol-producing yeast strains and uses thereof
|
|
WO2012113897A1
|
|
Antitumoral combination comprising cabazitaxel and cisplatin
|
|
EP2620148A1
|
|
Antitumoral combination comprising cabazitaxel and cisplatin
|
